Trade and Access to Medicines

Established in 2018, the Working Group on Trade Treaties and Access to Medicines was convened by the GDP Center to advance an evidence-based understanding of the impacts of trade and investment treaties on access to medicines. The goal of the Working Group–which was comprised of a dynamic group of economists, legal scholars, medical scientists and policy analysts from around the world–was to offer concrete policies and advice to help the trade and investment system be a tool in expanding global access to secure and affordable medicines.

The Working Group also advanced policy discourse at the World Trade Organization and at numerous regional and bilateral trade and investment treaties through direct engagement with policymakers, media, civil society and public dialogue.